Publications by authors named "S Moreno-Guillen"
Group A ß-hemolytic Streptococcus (S. pyogenes), also known as GAS, is a Gram-positive bacterium. It can be easily identified in the microbiology laboratory by its ability to hemolyse blood in culture media.
View Article and Find Full Text PDFArticle Synopsis
- - The study of the intestinal microbiota has gained attention due to its possible links to various diseases, including Crohn's disease, autism, diabetes, cancer, and obesity.
- - Probiotics, prebiotics, postbiotics, and fecal material transfer (FMT) are being explored as ways to modulate the microbiome, with FMT being the only proven effective treatment for recurrent colitis associated with Clostridioides difficile.
- - Despite advancements and the decreasing costs of microbiome research, there is still a lack of conclusive evidence for microbiome interventions in diseases other than R-CDI, necessitating interdisciplinary research and ethical considerations related to personalized medicine.
Meningococcal meningitis (MM) and invasive meningococcal disease remain a major public health problem that generates enormous public alarm. It is caused by Neisseria meningitidis, a Gram-negative diplococcus with an enormous capacity for acute and rapidly progressive disease, both episodic and epidemic in nature, with early diagnosis and treatment playing a major role. It occurs at any age, but is most common in children under 5 years of age followed by adolescents.
View Article and Find Full Text PDFArticle Synopsis
- - The study assessed the safety and effectiveness of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) after 144 weeks of dolutegravir (DTG)-based therapy in HIV-1 patients.
- - After 96 weeks on B/F/TAF, over 99% of participants maintained viral suppression and had stable CD4+ cell counts without emerging resistance, though some experienced mild side effects like diarrhea and weight gain.
- - The findings support the switch to B/F/TAF as a safe and effective long-term treatment option for people previously on DTG-containing regimens.
Article Synopsis
- Respiratory syncytial virus (RSV) has evolved from primarily affecting infants and immunosuppressed children to a common illness impacting all age groups, especially the elderly and those with immune issues.
- Advances in diagnostic testing have improved our understanding of RSV’s spread and effects, making it easier to identify.
- Recent developments in treatments, including long-lasting monoclonal antibodies and vaccines, have prompted a review of RSV by the ICOMEM to inform both medical professionals and the public about current knowledge and resources related to this infection in Spain.